Back to Search
Start Over
Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
- Source :
- Clinical Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
- Publication Year :
- 2024
- Publisher :
- Wiley, 2024.
-
Abstract
- Key Clinical Message Adalimumab has become essential for managing various chronic inflammatory diseases, including inflammatory bowel disease (IBD). While hematologic complications of adalimumab therapy are rare, they can have significant clinical implications. This report highlights the importance of recognizing and monitoring for neutropenia in patients receiving adalimumab treatment. We also describe the potential mechanisms and management strategies for this adverse event.
- Subjects :
- Adalimumab
Crohn's disease
fever
neutropenia
Medicine
Medicine (General)
R5-920
Subjects
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 12
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Clinical Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.5488e97e4b224ef6a3d1d2e995e70832
- Document Type :
- article
- Full Text :
- https://doi.org/10.1002/ccr3.8629